GILEAD SCIENCES, INC. Inventory, Finished Goods, Net of Reserves
GILEAD SCIENCES, INC. (GILD) had Inventory, Finished Goods, Net of Reserves of $1.72 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $1.72B.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $1.71B.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $1.65B.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $1.65B.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $1.72B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.71B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.65B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.65B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.60B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.51B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.45B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.42B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.33B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.35B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.27B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.32B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.33B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.28B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.07B 10-K · filed 2024-02-23 | |
| 2022-09-30 | $1.04B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $1.04B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.04B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.03B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $1.00B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.04B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.12B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $958.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $710.00M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $645.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $596.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $549.00M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $524.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $498.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $501.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $507.00M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $574.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $604.00M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $707.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $670.00M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $797.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $857.00M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $859.00M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $928.00M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $891.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $996.00M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $731.00M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $852.00M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $744.00M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $592.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $441.00M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $466.00M 10-K · filed 2016-02-24 | |
| 2014-09-30 | $450.89M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $559.98M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $547.66M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $593.00M 10-K · filed 2015-02-25 | $593.44M 10-K · filed 2014-02-25 |
| 2013-09-30 | $485.79M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $597.21M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $577.32M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $559.91M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $411.73M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $408.15M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $229.77M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $225.86M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $295.79M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $384.72M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $448.43M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $341.14M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $439.32M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $375.58M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $326.15M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |